In the field of routine single-dose toxicity studies, we occasionally meet with transient leukocytosis associated with an increase in fibrinogen in beagle dogs within a few days after treatment with the test article. Only a little is known, however, about the toxicological significance of these changes. However, these changes were thought to belong to the category of "Acute Phase Response, APR," which has been known for a long time in connection with injury, trauma or infection. Aiming at proper understanding of these experiences, we surveyed 25 single-dose toxicity studies (7 intravenous bolus, 5 intravenous infusion, 12 oral and 1 subcutaneous treatment, hereafter referred to simply as i.v. bolus, i.v. infusion, oral and s.c.) in beagle dogs, provided with data from hematological examinations. We set the following criteria as a positive response in the present survey: increases of 50% or more in either or both WBC or fibrinogen compared to the predosing value, transiently from Day 1 to Day 3 of the study.
INTRODUCTION
In the field of routine toxicological studies, we occasionally meet with transient leukocytosis associated with an increase in fibrinogen in beagle dogs within a few days after treatment with the test article. Only a little is known, however, about the toxicological significance of these changes. The objective of this survey was to study the characteristics of these changes aiming at proper understanding of their toxicological significance. In the present survey, 25 single-dose toxicity studies in beagle dogs, provided with data from hematological examinations, were examined.
MATERIALS AND METHODS
The studies surveyed 25 single-dose toxicity studies of various com-
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pounds were surveyed irrespective of the route of administration of the test article. These studies were only selected on the grounds of availability of hematological data from pretreatment and the first week of observation; therefore time points and items of examinations were not necessarily the same. The dose levels applied ranged from 0.1 to 300 mg/kg for intravenous application and from 250 to 2000 mg/kg for oral administration. Each of these studies consisted of 2 or 3 dose groups of 2 animals each.
Criteria for positive changes and evaluation of data Increases of about 50% or more in either or both white blood cells (WBC) or fibrinogen compared to the predosing value, transiently from Day 1 to Day 3, were taken as positive changes in principle in the present survey (increases of 50% or more are critical values for biologically significant changes which roughly coincide to the mean 2SD referring to background variations of these parameters in the author's laboratory). In humans, fibrinogen concentration has been reported to increase twofold to threefold in APR (Gewurz, 1982 All of the above-mentioned data were generated in our research laboratory using a Coulter Counter T890, Coagulometer ACL100 and automatic analyzer Monarch according to the standard operating procedures of the laboratory.
Evaluation of data
All data are evaluated on an individual basis and no statistical analysis was performed. . 1 shows the outline of the present survey. The routes of application in these studies consisted of 7 i.v. bolus, 5 i.v. infusion, 12 oral and 1 s.c. Among the studies surveyed, both WBC and fibrinogen data were present in 14 out of the 25 studies and only WBC data in the remainder. Of the 14 studies provided with both WBC and fibrinogen data, 11 studies were judged to exhibit significant increases in either or both WBC or fibrinogen transiently between Day 1 and Day 3 of studies. There were significant transient increases in both WBC and fibrinogen in 7 of the 11 studies. Two (2) studies exhibited only the change in fibrinogen. Two (2) studies exhibited the changes in WBC and fibrinogen, but the changes occurred irregularly between doses or individuals. There were no changes in either WBC or fibrinogen in the remaining 3 studies. Of the 11 studies provided with WBC count data, 4 studies exhibited significant transient WBC changes. In the case of studies provided with WBC and fibrinogen data, % changes in fibrinogen were larger than those in WBC counts except for 1 i.v. study.
RESULTS

Fig
As will be stated later, the studies subjected to the present survey employed various test articles, and therefore various signs ascribable to the biological activity of the respective test article were recorded in many studies. However, the above-mentioned changes in WBC counts and fibrinogen value were recognized independently of them. Table 1 shows a typical example of changes in fibrinogen and WBC in an i.v. infusion study which consisted of 3 dose groups (10, 30 and 100 mg/kg body weight) of 2 animals each (1 male and 1 female). As seen in the table, changes were only recorded on Day 1 for both WBC and fibrinogen except for 1 male of the high-dose group for fibrinogen, and the degree of the changes was dependent on the dosage levels. Three other studies (2 i.v. bolus and 1 i.v. infusion) with the same design as the example exhibited changes of a similar pattern. Table 2 shows further examples in which an increase in either WBC or fibrinogen was recorded. In sample study A (oral), data on both WBC and fibrinogen were available; however, the change was seen only in fibrinogen. In sample studies B (i.v. infusion) and C (oral), the change was seen in the WBC count. It was unknown, however, whether or not fibrinogen remained unchanged in these cases because of a lack of data. In sample study D (oral), changes were seen irregularly in WBC counts or fibrinogen values. Fig. 2 shows the relationship between the change in WBC and the change in the fibrinogen on Day 1 of 4 studies (a, b, c and d) consisting of a total of 24 animals. The data were collected from the 4 studies explained in the preceding paragraph concerning Table  1 . The appearance of changes in fibrinogen and WBC counts paralleled each other, showing dose-dependency in these studies. In the high-dose groups, the values were around 250 to 430% for fibrinogen and around 130 to 200% for WBC counts, and the values in the low-dose groups were around 100 to 150% for both items. The study was composed of 3 dose groups each consisting of 1 male and 1 female. Data are expressed as % of baseline values on Day -1. underline: significant change. All data are expressed as % of baseline values on Day -1. underline: significant change.
No fibrinogen data were available in sample studies B and C. various common signs of acute toxicity as vomiting occasionally with vomitus containing test article-like material, soft feces, diarrhea, flushing, paleness, cyanosis, abnormal body position, staggering gait, tachycardia, bradycardia, hypothermia and rarely epileptic symptom and respiratory arrest in 18/25 studies surveyed. These signs were observed only on Day 0 in many cases. In 1 s.c. study, ulceration around the application sites was observed. However, no changes in fibrinogen values or WBC counts were found in this study. As shown in this example, no relationship between the occurrence of acute toxic signs and changes in fibrinogen values or WBC counts was found in single-dose toxicity studies surveyed. Table 3 shows the results of survey of blood chemical and hematological changes in connection with the changes in fibrinogen and WBC counts. Among 15 studies with significant changes in fibrinogen and WBC counts, 3 studies exhibited such blood chemical changes as in ALP, GOT, GPT, BUN and total bilirubin in a dose-dependent manner coincidentally with the changes in fibrinogen and WBC counts. These changes were usually recorded, in contrast to the changes in fibrinogen and WBC counts, up to Day 6 or Day 13 in 2/3 studies. Eight (8) studies exhibited changes in various items. Items of change were almost the same as those mentioned in the foregoing statement; however, they sporadically occurred independent of the doses applied or the course of time. No changes in blood chemical or hematological examinations other than the fibrinogen and WBC counts were recorded in 2 studies.
Among 10 studies with no significant changes in fibrinogen or WBC counts, 2 studies reported marked changes in GOT, GPT, ALP, BUN, and total bilirubin in a dose-dependent manner. Some of these changes were recorded up to Day 13. Four (4) studies exhibited sporadic changes in various items. Another 4 studies reported no blood chemical or hematological changes. One (1, s.c.) of these studies reported ulceration around the application site. Table 4 shows frequency of main blood chemical and hematological changes recorded in 23 single-dose toxicity studies. There were no essential differences between the groups with and without the fibrinogen and WBC count changes except for the hematology data. The hematological findings in differential leukocyte counts (increased % of segmented neutrophils with decreased % of lymphocytes) recorded only in the group of studies with changes in fibrinogen and WBC counts was ascribed to leukocytosis.
In summary, the present survey revealed increases of 50% or more in either or both fibrinogen or WBC in a dose-dependent manner compared to the predosing value, transiently on Day 1 or Day 2 in about half of the 25 single-dose toxicity studies surveyed. Regarding blood chemical and hematological changes other than 
DISCUSSION
The present survey revealed transient increases in WBC count (leukocytosis) and fibrinogen on Day 1 or Day 2 after dosing in about 1/2 of the single-dose toxicity studies. The present survey also revealed no essential differences in other aspects of the study results between groups of studies with and without the changes in fibrinogen and WBC counts, and therefore the transient increases in WBC and fibrinogen found on a few days in acute toxicity studies were thought to be characteristic and to have occurred as incidents unrelated to other changes.
These changes were remarkable after the i.v. bolus and i.v. infusion dosing. The oral application produced similar effects; however, the incidence and severity were low compared to those after i.v. routes. Regarding this point, possible differences in exposure to the test article between the oral and intravenous application may be important.
Leukocytosis is known as the typical finding of inflammatory changes, especially in some bacterial infections; however, few drugs cause leukocytosis in contrast to the many that cause leukopenia (Majno and Joris, 1996) . On the other hand, one of the most sensitive responses to interleukin-1 is an increase in the number and immaturity of circulating neutrophils (Dinarello, 1984) . Fibrinogen is one of the important components of acute inflammatory exudate. According to Gewurz (1982) and Gregus and Klaassen (1996) , fibrinogen is a representative positive acute phase protein and the increase in fibrinogen is closely related to the increased erythrocyte sedimentation rate. Therefore, the increases in WBC and fibrinogen in the peripheral blood are a feature of any kind of tissue destruction resulting in inflammation. Regarding the above-mentioned points, it is worth mentioning that none of the animals used in the present survey exhibited any kind of tissue damage, including the sites of injection and of surgical operation for i.v. transfusion, except for 1 s.c. study. In addition, the present survey revealed that the reported changes in fibrinogen and WBC counts and other blood chemical findings occurred independently in many cases. Therefore, the changes in fibrinogen and WBC counts seem to have occurred due to unknown factors other than tissue damage rather than as an expression of inflammatory response.
According to Baumann and Gauldie (1994) , the cumulative homeostatic process against injury, trauma or infection is known as inflammation, and the early and immediate set of reactions that are induced are known as APR. The defense mechanisms must take priority over normal homeostatic states (Kushner, 1993) . Perhaps the most fundamental event in the initiation of APR is the production of a mediator molecule called interleukin-1 produced primarily from phagocytic cells (Dinarello, 1984) . From the pathological point of view, Majno and Joris (1996) included the abovementioned acute phase response in the 4 characteristic changes of the general effects of local injury and inflammation together with fever, leukocytosis and acceleration of erythrocyte sedimentation rate, which can develop within one day of significant injury. Pepys and Baltz (1983) stated that the stimuli which induce APR are diverse, but all include as a common denominator the production of cellular or tissue injury or death. They further stated that any substance, capable of appropriately triggering macrophages, may cause an APR from its potent capacity even if it has no other action or toxicity. In the textbook of Casarett and Doull's Toxicology, Burns et al. (1996) referred to APR in the section on innate immunity; however, they didn't make any comment on xenobiotic substances as causative agents. To our knowledge, no definite descriptions of any compounds which provoke APR are found in the literature except bacterial endotoxin and a phytotoxin abrin (Pepys and Baltz, 1983) . As above, APR itself is a widely known phenomenon; however, it is less familiar to toxicologists, especially in the field of routine toxicological study. This may be due to the circumstance that the major interest or purpose of the toxicity study generally is characterization of the specific toxicity of the test article rather than non-specific changes.
In the context of the present survey, however, no direct or indirect evidence suggesting activation of macrophages is available.
The test articles employed in the 25 single-dose toxicity studies surveyed were of various categories, and none of them were formulated and no pyrogen test data were provided. For this reason, we could not exclude some possibility of contamination of the test articles by endotoxin. The present survey, however, revealed that the oral application produced similar effects on WBC counts and fibrinogen value, as by the i.v. routes, though the incidence and severity were low compared to the i.v. routes. The present survey revealed that the increases in WBC counts and fibrinogen value were correlated and occurred dose-dependently to the doses applied in many studies. Regarding this point, dose-dependent fever in dogs after injection of lipopolysaccharide has been reported (LeMay et al., 1990) . However, the circumstance of variation in WBC and fibrinogen was by no means uniform among the studies surveyed; the reason for this variability may be either a difference in the study protocol of each study or a diversity in the macrophage activating potency of the respective test article as suggested by Pepys and Baltz (1983) .
In the present survey, transient increases in WBC counts and fibrinogen were recorded on a few days of the studies, and these changes were thought to be independent of specific toxicity of the test article. The reported changes seen in single-dose toxicity studies may belong to the category of acute phase response as the non-specific mechanism of living bodies as stated by Burns et al. (1996) .
